First Trust Investment Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.44M Sell
124,518
-151,180
-55% -$7.09M 0.73% 38
2024
Q2
$11.4M Buy
275,698
+39,460
+17% +$1.77M 1.61% 9
2024
Q1
$12.8M Buy
236,238
+3,633
+2% +$185K 2.26% 4
2023
Q4
$11.9M Buy
+232,605
New +$12.2M 2.48% 5

Other funds holding BMY

First Trust Investment Solutions's BMY Position: Q3 2024 in Review

First Trust Investment Solutions reduced its Bristol-Myers Squibb (BMY) stake by 55% in Q3 2024, selling an estimated $7.09M and leaving 124,518 shares worth $6.44M. The position accounts for 0.73% of the portfolio, ranked #38.

First Trust Investment Solutions first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. The position peaked at $12.8M in Q1 2024. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • First Trust Investment Solutions held 124,518 shares of Bristol-Myers Squibb worth $6.44M as of Q3 2024.
  • First Trust Investment Solutions sold 151,180 Bristol-Myers Squibb shares in Q3 2024, an estimated $7.09M.
  • Bristol-Myers Squibb made up 0.73% of First Trust Investment Solutions's portfolio in Q3 2024, its #38 holding.
  • First Trust Investment Solutions first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
  • First Trust Investment Solutions's Bristol-Myers Squibb position peaked at $12.8M in Q1 2024.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on First Trust Investment Solutions's 13F filing for Q3 2024, filed 13 Nov 2024.